⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 1, 2025

Table S5 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites

Tongtong Wu Zhicong Yang Sufan Tang Hongmei Yuan Yang Liu Haiyang Li Nan Liu Zhanwen Huang Yue Chen Zhijun Zhou

View Full Paper

Ask AI

Bookmark

Share

Key Points

Radioactive ligands targeting fibroblasts were studied using the U87MG tumor model.
The biodistribution data of [177Lu]Lu-DOTA-ALB-01 were presented as mean ± SD with n=3-5.
Key tissue uptake percentages were measured, providing insights into distribution.
Findings may enhance the development of targeted therapies in cancer treatment.

Implication

Experimental results show biodistribution of radioactive ligands in U87MG tumor model, indicating effectiveness in targeting fibroblasts.

Abstract

Table S5.Organ biodistribution of [177Lu]Lu-DOTA-ALB-01 in U87MG tumor model as %ID/g tissue. Data are expressed as mean ± SD (n=3-5).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d02af https://doi.org/10.1158/1535-7163.29759902

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S6 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
2Table S7 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
3Table S4 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
4Table S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
5Figure S13 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025